Pharmaceuticals, Biotechnology and Life Sciences
GARDEN CITY, N.Y., April 24, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a…
REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a…
New study establishes CHIPS as a foundation for engineered, vascularized, insulin-producing tissue systemsWALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) —…
Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN…
► Biomarker signatures were developed to predict histological treatment response to lanifibranor treatment in patients with MASH and fibrosis ► The…
LONDON, April 24, 2025 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a…
COPENHAGEN, Denmark, April 24, 2025 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter…
RIDGE is Largest Natural History Study Conducted with More Than 175 Participants Enrolled to Date with Arrhythmogenic Right Ventricular Cardiomyopathy…
SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) — Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by…
Vivoryon Therapeutics N.V. Signs Financing Agreementfor up to EUR 15 Million Halle (Saale) / Munich, Germany, April 24, 2025 –…